APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Xerostomia (Dry Mouth) Therapeutics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Xerostomia (Dry Mouth) Therapeutics Market Analysis and Forecast 2026-2032

Report ID 17404807022 January 2026193 pages

Choose your research edition.

Industry ResearchXerostomia (Dry Mouth) Therapeutics Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Xerostomia (Dry Mouth) Therapeutics Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Xerostomia (Dry Mouth) Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Xerostomia (Dry Mouth) Therapeutics Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Xerostomia (Dry Mouth) Therapeutics Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Xerostomia (Dry Mouth) Therapeutics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Xerostomia (Dry Mouth) Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Xerostomia (Dry Mouth) Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Xerostomia (Dry Mouth) Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Xerostomia (Dry Mouth) Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Xerostomia (Dry Mouth) Therapeutics include Acacia Pharma, Church & Dwight, Inc., Colgate-Palmolive Company, Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals, Inc., OraCoat, Parnell Pharmaceuticals, Inc., Pendopharm and GlaxoSmithKline plc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Xerostomia (Dry Mouth) Therapeutics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Xerostomia (Dry Mouth) Therapeutics, also provides the sales of main regions and countries. Of the upcoming market potential for Xerostomia (Dry Mouth) Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Xerostomia (Dry Mouth) Therapeutics sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Xerostomia (Dry Mouth) Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Xerostomia (Dry Mouth) Therapeutics sales, projected growth trends, production technology, application and end-user industry.

Xerostomia (Dry Mouth) Therapeutics Segment by Company

Acacia Pharma

Church & Dwight, Inc.

Colgate-Palmolive Company

Hikma Pharmaceuticals PLC

Lupin Pharmaceuticals, Inc.

OraCoat

Parnell Pharmaceuticals, Inc.

Pendopharm

GlaxoSmithKline plc

Pfizer, Inc.

Sun Pharmaceuticals Industries Ltd.

Xerostomia (Dry Mouth) Therapeutics Segment by Type

Salivary Stimulants

Salivary Substitutes

Dentifrices

Xerostomia (Dry Mouth) Therapeutics Segment by Application

OTC

Prescription

Xerostomia (Dry Mouth) Therapeutics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Xerostomia (Dry Mouth) Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Xerostomia (Dry Mouth) Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Xerostomia (Dry Mouth) Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Xerostomia (Dry Mouth) Therapeutics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Xerostomia (Dry Mouth) Therapeutics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Xerostomia (Dry Mouth) Therapeutics sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Xerostomia (Dry Mouth) Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Salivary Stimulants Major Manufacturers Table 3. Salivary Substitutes Major Manufacturers Table 4. Dentifrices Major Manufacturers Table 5. Global Xerostomia (Dry Mouth) Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. OTC Major Manufacturers Table 7. Prescription Major Manufacturers Table 8. Xerostomia (Dry Mouth) Therapeutics Industry Trends Table 9. Xerostomia (Dry Mouth) Therapeutics Industry Drivers Table 10. Xerostomia (Dry Mouth) Therapeutics Industry Opportunities and Challenges Table 11. Xerostomia (Dry Mouth) Therapeutics Industry Restraints Table 12. Global Xerostomia (Dry Mouth) Therapeutics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Xerostomia (Dry Mouth) Therapeutics Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Xerostomia (Dry Mouth) Therapeutics Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Region (2021-2026) Table 16. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Region (2027-2032) Table 17. Global Xerostomia (Dry Mouth) Therapeutics Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Tons) Table 18. Global Xerostomia (Dry Mouth) Therapeutics Sales by Region (2021-2026) & (W Tons) Table 19. Global Xerostomia (Dry Mouth) Therapeutics Sales by Region (2027-2032) & (W Tons) Table 20. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Region (2021-2026) Table 21. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Region (2027-2032) Table 22. Global Xerostomia (Dry Mouth) Therapeutics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Xerostomia (Dry Mouth) Therapeutics Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Manufacturers (2021-2026) Table 26. Global Xerostomia (Dry Mouth) Therapeutics Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 27. Global Xerostomia (Dry Mouth) Therapeutics Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Xerostomia (Dry Mouth) Therapeutics Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Xerostomia (Dry Mouth) Therapeutics Manufacturers, Product Type & Application Table 30. Global Xerostomia (Dry Mouth) Therapeutics Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Xerostomia (Dry Mouth) Therapeutics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Xerostomia (Dry Mouth) Therapeutics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Xerostomia (Dry Mouth) Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Xerostomia (Dry Mouth) Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Type (2021-2026) Table 37. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Type (2027-2032) Table 38. Global Xerostomia (Dry Mouth) Therapeutics Sales by Type 2021 VS 2025 VS 2032 (W Tons) Table 39. Global Xerostomia (Dry Mouth) Therapeutics Sales by Type (2021-2026) & (W Tons) Table 40. Global Xerostomia (Dry Mouth) Therapeutics Sales by Type (2027-2032) & (W Tons) Table 41. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2021-2026) Table 42. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2027-2032) Table 43. Global Xerostomia (Dry Mouth) Therapeutics Price by Type (2021-2026) & (US$/Ton) Table 44. Global Xerostomia (Dry Mouth) Therapeutics Price by Type (2027-2032) & (US$/Ton) Table 45. Global Xerostomia (Dry Mouth) Therapeutics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Xerostomia (Dry Mouth) Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Xerostomia (Dry Mouth) Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Application (2021-2026) Table 49. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Application (2027-2032) Table 50. Global Xerostomia (Dry Mouth) Therapeutics Sales by Application 2021 VS 2025 VS 2032 (W Tons) Table 51. Global Xerostomia (Dry Mouth) Therapeutics Sales by Application (2021-2026) & (W Tons) Table 52. Global Xerostomia (Dry Mouth) Therapeutics Sales by Application (2027-2032) & (W Tons) Table 53. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2021-2026) Table 54. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2027-2032) Table 55. Global Xerostomia (Dry Mouth) Therapeutics Price by Application (2021-2026) & (US$/Ton) Table 56. Global Xerostomia (Dry Mouth) Therapeutics Price by Application (2027-2032) & (US$/Ton) Table 57. Acacia Pharma Company Information Table 58. Acacia Pharma Business Overview Table 59. Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 60. Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Product Portfolio Table 61. Acacia Pharma Recent Development Table 62. Church & Dwight, Inc. Company Information Table 63. Church & Dwight, Inc. Business Overview Table 64. Church & Dwight, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 65. Church & Dwight, Inc. Xerostomia (Dry Mouth) Therapeutics Product Portfolio Table 66. Church & Dwight, Inc. Recent Development Table 67. Colgate-Palmolive Company Company Information Table 68. Colgate-Palmolive Company Business Overview Table 69. Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 70. Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Product Portfolio Table 71. Colgate-Palmolive Company Recent Development Table 72. Hikma Pharmaceuticals PLC Company Information Table 73. Hikma Pharmaceuticals PLC Business Overview Table 74. Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Product Portfolio Table 76. Hikma Pharmaceuticals PLC Recent Development Table 77. Lupin Pharmaceuticals, Inc. Company Information Table 78. Lupin Pharmaceuticals, Inc. Business Overview Table 79. Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Product Portfolio Table 81. Lupin Pharmaceuticals, Inc. Recent Development Table 82. OraCoat Company Information Table 83. OraCoat Business Overview Table 84. OraCoat Xerostomia (Dry Mouth) Therapeutics Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. OraCoat Xerostomia (Dry Mouth) Therapeutics Product Portfolio Table 86. OraCoat Recent Development Table 87. Parnell Pharmaceuticals, Inc. Company Information Table 88. Parnell Pharmaceuticals, Inc. Business Overview Table 89. Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Product Portfolio Table 91. Parnell Pharmaceuticals, Inc. Recent Development Table 92. Pendopharm Company Information Table 93. Pendopharm Business Overview Table 94. Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. Pendopharm Xerostomia (Dry Mouth) Therapeutics Product Portfolio Table 96. Pendopharm Recent Development Table 97. GlaxoSmithKline plc Company Information Table 98. GlaxoSmithKline plc Business Overview Table 99. GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 100. GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Product Portfolio Table 101. GlaxoSmithKline plc Recent Development Table 102. Pfizer, Inc. Company Information Table 103. Pfizer, Inc. Business Overview Table 104. Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 105. Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Product Portfolio Table 106. Pfizer, Inc. Recent Development Table 107. Sun Pharmaceuticals Industries Ltd. Company Information Table 108. Sun Pharmaceuticals Industries Ltd. Business Overview Table 109. Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 110. Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Product Portfolio Table 111. Sun Pharmaceuticals Industries Ltd. Recent Development Table 112. North America Xerostomia (Dry Mouth) Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 113. North America Xerostomia (Dry Mouth) Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 114. North America Xerostomia (Dry Mouth) Therapeutics Sales by Type (2021-2026) & (W Tons) Table 115. North America Xerostomia (Dry Mouth) Therapeutics Sales by Type (2027-2032) & (W Tons) Table 116. North America Xerostomia (Dry Mouth) Therapeutics Sales Price by Type (2021-2026) & (US$/Ton) Table 117. North America Xerostomia (Dry Mouth) Therapeutics Sales Price by Type (2027-2032) & (US$/Ton) Table 118. North America Xerostomia (Dry Mouth) Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 119. North America Xerostomia (Dry Mouth) Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 120. North America Xerostomia (Dry Mouth) Therapeutics Sales by Application (2021-2026) & (W Tons) Table 121. North America Xerostomia (Dry Mouth) Therapeutics Sales by Application (2027-2032) & (W Tons) Table 122. North America Xerostomia (Dry Mouth) Therapeutics Sales Price by Application (2021-2026) & (US$/Ton) Table 123. North America Xerostomia (Dry Mouth) Therapeutics Sales Price by Application (2027-2032) & (US$/Ton) Table 124. North America Xerostomia (Dry Mouth) Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Xerostomia (Dry Mouth) Therapeutics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 126. North America Xerostomia (Dry Mouth) Therapeutics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 127. North America Xerostomia (Dry Mouth) Therapeutics Sales by Country (2021 VS 2025 VS 2032) & (W Tons) Table 128. North America Xerostomia (Dry Mouth) Therapeutics Sales by Country (2021-2026) & (W Tons) Table 129. North America Xerostomia (Dry Mouth) Therapeutics Sales by Country (2027-2032) & (W Tons) Table 130. North America Xerostomia (Dry Mouth) Therapeutics Sales Price by Country (2021-2026) & (US$/Ton) Table 131. North America Xerostomia (Dry Mouth) Therapeutics Sales Price by Country (2027-2032) & (US$/Ton) Table 132. United States Xerostomia (Dry Mouth) Therapeutics Revenue (2021-2032) & (US$ Million) Table 133. Canada Xerostomia (Dry Mouth) Therapeutics Revenue (2021-2032) & (US$ Million) Table 134. Europe Xerostomia (Dry Mouth) Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 135. Europe Xerostomia (Dry Mouth) Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 136. Europe Xerostomia (Dry Mouth) Therapeutics Sales by Type (2021-2026) & (W Tons) Table 137. Europe Xerostomia (Dry Mouth) Therapeutics Sales by Type (2027-2032) & (W Tons) Table 138. Europe Xerostomia (Dry Mouth) Therapeutics Sales Price by Type (2021-2026) & (US$/Ton) Table 139. Europe Xerostomia (Dry Mouth) Therapeutics Sales Price by Type (2027-2032) & (US$/Ton) Table 140. Europe Xerostomia (Dry Mouth) Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 141. Europe Xerostomia (Dry Mouth) Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 142. Europe Xerostomia (Dry Mouth) Therapeutics Sales by Application (2021-2026) & (W Tons) Table 143. Europe Xerostomia (Dry Mouth) Therapeutics Sales by Application (2027-2032) & (W Tons) Table 144. Europe Xerostomia (Dry Mouth) Therapeutics Sales Price by Application (2021-2026) & (US$/Ton) Table 145. Europe Xerostomia (Dry Mouth) Therapeutics Sales Price by Application (2027-2032) & (US$/Ton) Table 146. Europe Xerostomia (Dry Mouth) Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Europe Xerostomia (Dry Mouth) Therapeutics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 148. Europe Xerostomia (Dry Mouth) Therapeutics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 149. Europe Xerostomia (Dry Mouth) Therapeutics Sales by Country (2021 VS 2025 VS 2032) & (W Tons) Table 150. Europe Xerostomia (Dry Mouth) Therapeutics Sales by Country (2021-2026) & (W Tons) Table 151. Europe Xerostomia (Dry Mouth) Therapeutics Sales by Country (2027-2032) & (W Tons) Table 152. Europe Xerostomia (Dry Mouth) Therapeutics Sales Price by Country (2021-2026) & (US$/Ton) Table 153. Europe Xerostomia (Dry Mouth) Therapeutics Sales Price by Country (2027-2032) & (US$/Ton) Table 154. Germany Xerostomia (Dry Mouth) Therapeutics Revenue (2021-2032) & (US$ Million) Table 155. France Xerostomia (Dry Mouth) Therapeutics Revenue (2021-2032) & (US$ Million) Table 156. U.K. Xerostomia (Dry Mouth) Therapeutics Revenue (2021-2032) & (US$ Million) Table 157. Italy Xerostomia (Dry Mouth) Therapeutics Revenue (2021-2032) & (US$ Million) Table 158. Netherlands Xerostomia (Dry Mouth) Therapeutics Revenue (2021-2032) & (US$ Million) Table 159. China Xerostomia (Dry Mouth) Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 160. China Xerostomia (Dry Mouth) Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 161. China Xerostomia (Dry Mouth) Therapeutics Sales by Type (2021-2026) & (W Tons) Table 162. China Xerostomia (Dry Mouth) Therapeutics Sales by Type (2027-2032) & (W Tons) Table 163. China Xerostomia (Dry Mouth) Therapeutics Sales Price by Type (2021-2026) & (US$/Ton) Table 164. China Xerostomia (Dry Mouth) Therapeutics Sales Price by Type (2027-2032) & (US$/Ton) Table 165. China Xerostomia (Dry Mouth) Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 166. China Xerostomia (Dry Mouth) Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 167. China Xerostomia (Dry Mouth) Therapeutics Sales by Application (2021-2026) & (W Tons) Table 168. China Xerostomia (Dry Mouth) Therapeutics Sales by Application (2027-2032) & (W Tons) Table 169. China Xerostomia (Dry Mouth) Therapeutics Sales Price by Application (2021-2026) & (US$/Ton) Table 170. China Xerostomia (Dry Mouth) Therapeutics Sales Price by Application (2027-2032) & (US$/Ton) Table 171. Asia Xerostomia (Dry Mouth) Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 172. Asia Xerostomia (Dry Mouth) Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 173. Asia Xerostomia (Dry Mouth) Therapeutics Sales by Type (2021-2026) & (W Tons) Table 174. Asia Xerostomia (Dry Mouth) Therapeutics Sales by Type (2027-2032) & (W Tons) Table 175. Asia Xerostomia (Dry Mouth) Therapeutics Sales Price by Type (2021-2026) & (US$/Ton) Table 176. Asia Xerostomia (Dry Mouth) Therapeutics Sales Price by Type (2027-2032) & (US$/Ton) Table 177. Asia Xerostomia (Dry Mouth) Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 178. Asia Xerostomia (Dry Mouth) Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 179. Asia Xerostomia (Dry Mouth) Therapeutics Sales by Application (2021-2026) & (W Tons) Table 180. Asia Xerostomia (Dry Mouth) Therapeutics Sales by Application (2027-2032) & (W Tons) Table 181. Asia Xerostomia (Dry Mouth) Therapeutics Sales Price by Application (2021-2026) & (US$/Ton) Table 182. Asia Xerostomia (Dry Mouth) Therapeutics Sales Price by Application (2027-2032) & (US$/Ton) Table 183. Asia Xerostomia (Dry Mouth) Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 184. Asia Xerostomia (Dry Mouth) Therapeutics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 185. Asia Xerostomia (Dry Mouth) Therapeutics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 186. Asia Xerostomia (Dry Mouth) Therapeutics Sales by Country (2021 VS 2025 VS 2032) & (W Tons) Table 187. Asia Xerostomia (Dry Mouth) Therapeutics Sales by Country (2021-2026) & (W Tons) Table 188. Asia Xerostomia (Dry Mouth) Therapeutics Sales by Country (2027-2032) & (W Tons) Table 189. Asia Xerostomia (Dry Mouth) Therapeutics Sales Price by Country (2021-2026) & (US$/Ton) Table 190. Asia Xerostomia (Dry Mouth) Therapeutics Sales Price by Country (2027-2032) & (US$/Ton) Table 191. Japan Xerostomia (Dry Mouth) Therapeutics Revenue (2021-2032) & (US$ Million) Table 192. South Korea Xerostomia (Dry Mouth) Therapeutics Revenue (2021-2032) & (US$ Million) Table 193. India Xerostomia (Dry Mouth) Therapeutics Revenue (2021-2032) & (US$ Million) Table 194. Australia Xerostomia (Dry Mouth) Therapeutics Revenue (2021-2032) & (US$ Million) Table 195. China Taiwan Xerostomia (Dry Mouth) Therapeutics Revenue (2021-2032) & (US$ Million) Table 196. Southeast Asia Xerostomia (Dry Mouth) Therapeutics Revenue (2021-2032) & (US$ Million) Table 197. SAMEA Xerostomia (Dry Mouth) Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 198. SAMEA Xerostomia (Dry Mouth) Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 199. SAMEA Xerostomia (Dry Mouth) Therapeutics Sales by Type (2021-2026) & (W Tons) Table 200. SAMEA Xerostomia (Dry Mouth) Therapeutics Sales by Type (2027-2032) & (W Tons) Table 201. SAMEA Xerostomia (Dry Mouth) Therapeutics Sales Price by Type (2021-2026) & (US$/Ton) Table 202. SAMEA Xerostomia (Dry Mouth) Therapeutics Sales Price by Type (2027-2032) & (US$/Ton) Table 203. SAMEA Xerostomia (Dry Mouth) Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 204. SAMEA Xerostomia (Dry Mouth) Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 205. SAMEA Xerostomia (Dry Mouth) Therapeutics Sales by Application (2021-2026) & (W Tons) Table 206. SAMEA Xerostomia (Dry Mouth) Therapeutics Sales by Application (2027-2032) & (W Tons) Table 207. SAMEA Xerostomia (Dry Mouth) Therapeutics Sales Price by Application (2021-2026) & (US$/Ton) Table 208. SAMEA Xerostomia (Dry Mouth) Therapeutics Sales Price by Application (2027-2032) & (US$/Ton) Table 209. SAMEA Xerostomia (Dry Mouth) Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 210. SAMEA Xerostomia (Dry Mouth) Therapeutics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 211. SAMEA Xerostomia (Dry Mouth) Therapeutics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 212. SAMEA Xerostomia (Dry Mouth) Therapeutics Sales by Country (2021 VS 2025 VS 2032) & (W Tons) Table 213. SAMEA Xerostomia (Dry Mouth) Therapeutics Sales by Country (2021-2026) & (W Tons) Table 214. SAMEA Xerostomia (Dry Mouth) Therapeutics Sales by Country (2027-2032) & (W Tons) Table 215. SAMEA Xerostomia (Dry Mouth) Therapeutics Sales Price by Country (2021-2026) & (US$/Ton) Table 216. SAMEA Xerostomia (Dry Mouth) Therapeutics Sales Price by Country (2027-2032) & (US$/Ton) Table 217. Brazil Xerostomia (Dry Mouth) Therapeutics Revenue (2021-2032) & (US$ Million) Table 218. Argentina Xerostomia (Dry Mouth) Therapeutics Revenue (2021-2032) & (US$ Million) Table 219. Chile Xerostomia (Dry Mouth) Therapeutics Revenue (2021-2032) & (US$ Million) Table 220. Colombia Xerostomia (Dry Mouth) Therapeutics Revenue (2021-2032) & (US$ Million) Table 221. Peru Xerostomia (Dry Mouth) Therapeutics Revenue (2021-2032) & (US$ Million) Table 222. Saudi Arabia Xerostomia (Dry Mouth) Therapeutics Revenue (2021-2032) & (US$ Million) Table 223. Israel Xerostomia (Dry Mouth) Therapeutics Revenue (2021-2032) & (US$ Million) Table 224. UAE Xerostomia (Dry Mouth) Therapeutics Revenue (2021-2032) & (US$ Million) Table 225. Turkey Xerostomia (Dry Mouth) Therapeutics Revenue (2021-2032) & (US$ Million) Table 226. Iran Xerostomia (Dry Mouth) Therapeutics Revenue (2021-2032) & (US$ Million) Table 227. Egypt Xerostomia (Dry Mouth) Therapeutics Revenue (2021-2032) & (US$ Million) Table 228. Key Raw Materials Table 229. Raw Materials Key Suppliers Table 230. Xerostomia (Dry Mouth) Therapeutics Distributors List Table 231. Xerostomia (Dry Mouth) Therapeutics Customers List Table 232. Research Programs/Design for This Report Table 233. Authors List of This Report Table 234. Secondary Sources Table 235. Primary Sources List of Figures Figure 1. Xerostomia (Dry Mouth) Therapeutics Image Figure 2. Global Xerostomia (Dry Mouth) Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Xerostomia (Dry Mouth) Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Salivary Stimulants Image Figure 5. Salivary Substitutes Image Figure 6. Dentifrices Image Figure 7. Global Xerostomia (Dry Mouth) Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Xerostomia (Dry Mouth) Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 9. OTC Image Figure 10. Prescription Image Figure 11. Global Xerostomia (Dry Mouth) Therapeutics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Xerostomia (Dry Mouth) Therapeutics Revenue (2021-2032) & (US$ Million) Figure 13. Global Xerostomia (Dry Mouth) Therapeutics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Region (2021-2032) Figure 16. Global Xerostomia (Dry Mouth) Therapeutics Sales (2021-2032) & (W Tons) Figure 17. Global Xerostomia (Dry Mouth) Therapeutics Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Figure 18. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Xerostomia (Dry Mouth) Therapeutics Sales YoY (2021-2032) & (W Tons) Figure 20. Europe Xerostomia (Dry Mouth) Therapeutics Sales YoY (2021-2032) & (W Tons) Figure 21. China Xerostomia (Dry Mouth) Therapeutics Sales YoY (2021-2032) & (W Tons) Figure 22. Asia (Excluding China) Xerostomia (Dry Mouth) Therapeutics Sales YoY (2021-2032) & (W Tons) Figure 23. South America, Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Sales YoY (2021-2032) & (W Tons) Figure 24. Global Xerostomia (Dry Mouth) Therapeutics Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Xerostomia (Dry Mouth) Therapeutics Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Xerostomia (Dry Mouth) Therapeutics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Type (2021-2032) Figure 30. Global Xerostomia (Dry Mouth) Therapeutics Sales by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 31. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2021-2032) Figure 33. Global Xerostomia (Dry Mouth) Therapeutics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Application (2021-2032) Figure 36. Global Xerostomia (Dry Mouth) Therapeutics Sales by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 37. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2021-2032) Figure 39. North America Xerostomia (Dry Mouth) Therapeutics Revenue Share by Type (2021-2032) Figure 40. North America Xerostomia (Dry Mouth) Therapeutics Sales Share by Type (2021-2032) Figure 41. North America Xerostomia (Dry Mouth) Therapeutics Revenue Share by Application (2021-2032) Figure 42. North America Xerostomia (Dry Mouth) Therapeutics Sales Share by Application (2021-2032) Figure 43. North America Xerostomia (Dry Mouth) Therapeutics Revenue Share by Country (2021-2032) Figure 44. North America Xerostomia (Dry Mouth) Therapeutics Sales Share by Country (2021-2032) Figure 45. Europe Xerostomia (Dry Mouth) Therapeutics Revenue Share by Type (2021-2032) Figure 46. Europe Xerostomia (Dry Mouth) Therapeutics Sales Share by Type (2021-2032) Figure 47. Europe Xerostomia (Dry Mouth) Therapeutics Revenue Share by Application (2021-2032) Figure 48. Europe Xerostomia (Dry Mouth) Therapeutics Sales Share by Application (2021-2032) Figure 49. Europe Xerostomia (Dry Mouth) Therapeutics Revenue Share by Country (2021-2032) Figure 50. Europe Xerostomia (Dry Mouth) Therapeutics Sales Share by Country (2021-2032) Figure 51. China Xerostomia (Dry Mouth) Therapeutics Revenue Share by Type (2021-2032) Figure 52. China Xerostomia (Dry Mouth) Therapeutics Sales Share by Type (2021-2032) Figure 53. China Xerostomia (Dry Mouth) Therapeutics Revenue Share by Application (2021-2032) Figure 54. China Xerostomia (Dry Mouth) Therapeutics Sales Share by Application (2021-2032) Figure 55. Asia Xerostomia (Dry Mouth) Therapeutics Revenue Share by Type (2021-2032) Figure 56. Asia Xerostomia (Dry Mouth) Therapeutics Sales Share by Type (2021-2032) Figure 57. Asia Xerostomia (Dry Mouth) Therapeutics Revenue Share by Application (2021-2032) Figure 58. Asia Xerostomia (Dry Mouth) Therapeutics Sales Share by Application (2021-2032) Figure 59. Asia Xerostomia (Dry Mouth) Therapeutics Revenue Share by Country (2021-2032) Figure 60. Asia Xerostomia (Dry Mouth) Therapeutics Sales Share by Country (2021-2032) Figure 61. SAMEA Xerostomia (Dry Mouth) Therapeutics Revenue Share by Type (2021-2032) Figure 62. SAMEA Xerostomia (Dry Mouth) Therapeutics Sales Share by Type (2021-2032) Figure 63. SAMEA Xerostomia (Dry Mouth) Therapeutics Revenue Share by Application (2021-2032) Figure 64. SAMEA Xerostomia (Dry Mouth) Therapeutics Sales Share by Application (2021-2032) Figure 65. SAMEA Xerostomia (Dry Mouth) Therapeutics Revenue Share by Country (2021-2032) Figure 66. SAMEA Xerostomia (Dry Mouth) Therapeutics Sales Share by Country (2021-2032) Figure 67. Xerostomia (Dry Mouth) Therapeutics Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Xerostomia (Dry Mouth) Therapeutics Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Salivary Stimulants
  • Salivary Substitutes
  • Dentifrices
Applications
  • OTC
  • Prescription
Companies covered
  • Acacia Pharma
  • Church & Dwight, Inc.
  • Colgate-Palmolive Company
  • Hikma Pharmaceuticals PLC
  • Lupin Pharmaceuticals, Inc.
  • OraCoat
  • Parnell Pharmaceuticals, Inc.
  • Pendopharm
  • GlaxoSmithKline plc
  • Pfizer, Inc.
  • Sun Pharmaceuticals Industries Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Xerostomia (Dry Mouth) Therapeutics Market by Type
  3. 1.2.1 Global Xerostomia (Dry Mouth) Therapeutics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Salivary Stimulants
  5. 1.2.3 Salivary Substitutes
  6. 1.2.4 Dentifrices
  7. 1.3 Xerostomia (Dry Mouth) Therapeutics Market by Application
  8. 1.3.1 Global Xerostomia (Dry Mouth) Therapeutics Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 OTC
  10. 1.3.3 Prescription
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Xerostomia (Dry Mouth) Therapeutics Market Dynamics
  1. 2.1 Xerostomia (Dry Mouth) Therapeutics Industry Trends
  2. 2.2 Xerostomia (Dry Mouth) Therapeutics Industry Drivers
  3. 2.3 Xerostomia (Dry Mouth) Therapeutics Industry Opportunities and Challenges
  4. 2.4 Xerostomia (Dry Mouth) Therapeutics Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Xerostomia (Dry Mouth) Therapeutics Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue by Region
  3. 3.2.1 Global Xerostomia (Dry Mouth) Therapeutics Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue by Region (2021-2026)
  5. 3.2.3 Global Xerostomia (Dry Mouth) Therapeutics Revenue by Region (2027-2032)
  6. 3.2.4 Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Xerostomia (Dry Mouth) Therapeutics Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Xerostomia (Dry Mouth) Therapeutics Sales by Region
  9. 3.4.1 Global Xerostomia (Dry Mouth) Therapeutics Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Xerostomia (Dry Mouth) Therapeutics Sales by Region (2021-2026)
  11. 3.4.3 Global Xerostomia (Dry Mouth) Therapeutics Sales by Region (2027-2032)
  12. 3.4.4 Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Xerostomia (Dry Mouth) Therapeutics Revenue by Manufacturers
  2. 4.1.1 Global Xerostomia (Dry Mouth) Therapeutics Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Xerostomia (Dry Mouth) Therapeutics Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Xerostomia (Dry Mouth) Therapeutics Sales by Manufacturers
  6. 4.2.1 Global Xerostomia (Dry Mouth) Therapeutics Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Xerostomia (Dry Mouth) Therapeutics Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Xerostomia (Dry Mouth) Therapeutics Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Xerostomia (Dry Mouth) Therapeutics Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Xerostomia (Dry Mouth) Therapeutics Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Xerostomia (Dry Mouth) Therapeutics Manufacturers, Product Type & Application
  13. 4.7 Global Xerostomia (Dry Mouth) Therapeutics Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Xerostomia (Dry Mouth) Therapeutics Market CR5 and HHI
  16. 4.8.2 2025 Xerostomia (Dry Mouth) Therapeutics Tier 1, Tier 2, and Tier 3
5 Xerostomia (Dry Mouth) Therapeutics Market by Type
  1. 5.1 Global Xerostomia (Dry Mouth) Therapeutics Revenue by Type
  2. 5.1.1 Global Xerostomia (Dry Mouth) Therapeutics Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Xerostomia (Dry Mouth) Therapeutics Sales by Type
  6. 5.2.1 Global Xerostomia (Dry Mouth) Therapeutics Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Xerostomia (Dry Mouth) Therapeutics Sales by Type (2021-2032) & (W Tons)
  8. 5.2.3 Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Type (2021-2032)
  9. 5.3 Global Xerostomia (Dry Mouth) Therapeutics Price by Type
6 Xerostomia (Dry Mouth) Therapeutics Market by Application
  1. 6.1 Global Xerostomia (Dry Mouth) Therapeutics Revenue by Application
  2. 6.1.1 Global Xerostomia (Dry Mouth) Therapeutics Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Xerostomia (Dry Mouth) Therapeutics Sales by Application
  6. 6.2.1 Global Xerostomia (Dry Mouth) Therapeutics Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Xerostomia (Dry Mouth) Therapeutics Sales by Application (2021-2032) & (W Tons)
  8. 6.2.3 Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2021-2032)
  9. 6.3 Global Xerostomia (Dry Mouth) Therapeutics Price by Application
7 Company Profiles
  1. 7.1 Acacia Pharma
  2. 7.1.1 Acacia Pharma Company Information
  3. 7.1.2 Acacia Pharma Business Overview
  4. 7.1.3 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Product Portfolio
  6. 7.1.5 Acacia Pharma Recent Developments
  7. 7.2 Church & Dwight, Inc.
  8. 7.2.1 Church & Dwight, Inc. Company Information
  9. 7.2.2 Church & Dwight, Inc. Business Overview
  10. 7.2.3 Church & Dwight, Inc. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Church & Dwight, Inc. Xerostomia (Dry Mouth) Therapeutics Product Portfolio
  12. 7.2.5 Church & Dwight, Inc. Recent Developments
  13. 7.3 Colgate-Palmolive Company
  14. 7.3.1 Colgate-Palmolive Company Company Information
  15. 7.3.2 Colgate-Palmolive Company Business Overview
  16. 7.3.3 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Product Portfolio
  18. 7.3.5 Colgate-Palmolive Company Recent Developments
  19. 7.4 Hikma Pharmaceuticals PLC
  20. 7.4.1 Hikma Pharmaceuticals PLC Company Information
  21. 7.4.2 Hikma Pharmaceuticals PLC Business Overview
  22. 7.4.3 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Product Portfolio
  24. 7.4.5 Hikma Pharmaceuticals PLC Recent Developments
  25. 7.5 Lupin Pharmaceuticals, Inc.
  26. 7.5.1 Lupin Pharmaceuticals, Inc. Company Information
  27. 7.5.2 Lupin Pharmaceuticals, Inc. Business Overview
  28. 7.5.3 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Product Portfolio
  30. 7.5.5 Lupin Pharmaceuticals, Inc. Recent Developments
  31. 7.6 OraCoat
  32. 7.6.1 OraCoat Company Information
  33. 7.6.2 OraCoat Business Overview
  34. 7.6.3 OraCoat Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 OraCoat Xerostomia (Dry Mouth) Therapeutics Product Portfolio
  36. 7.6.5 OraCoat Recent Developments
  37. 7.7 Parnell Pharmaceuticals, Inc.
  38. 7.7.1 Parnell Pharmaceuticals, Inc. Company Information
  39. 7.7.2 Parnell Pharmaceuticals, Inc. Business Overview
  40. 7.7.3 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Product Portfolio
  42. 7.7.5 Parnell Pharmaceuticals, Inc. Recent Developments
  43. 7.8 Pendopharm
  44. 7.8.1 Pendopharm Company Information
  45. 7.8.2 Pendopharm Business Overview
  46. 7.8.3 Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Pendopharm Xerostomia (Dry Mouth) Therapeutics Product Portfolio
  48. 7.8.5 Pendopharm Recent Developments
  49. 7.9 GlaxoSmithKline plc
  50. 7.9.1 GlaxoSmithKline plc Company Information
  51. 7.9.2 GlaxoSmithKline plc Business Overview
  52. 7.9.3 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Product Portfolio
  54. 7.9.5 GlaxoSmithKline plc Recent Developments
  55. 7.10 Pfizer, Inc.
  56. 7.10.1 Pfizer, Inc. Company Information
  57. 7.10.2 Pfizer, Inc. Business Overview
  58. 7.10.3 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Product Portfolio
  60. 7.10.5 Pfizer, Inc. Recent Developments
  61. 7.11 Sun Pharmaceuticals Industries Ltd.
  62. 7.11.1 Sun Pharmaceuticals Industries Ltd. Company Information
  63. 7.11.2 Sun Pharmaceuticals Industries Ltd. Business Overview
  64. 7.11.3 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Product Portfolio
  66. 7.11.5 Sun Pharmaceuticals Industries Ltd. Recent Developments
8 North America
  1. 8.1 North America Xerostomia (Dry Mouth) Therapeutics Market Size by Type
  2. 8.1.1 North America Xerostomia (Dry Mouth) Therapeutics Revenue by Type (2021-2032)
  3. 8.1.2 North America Xerostomia (Dry Mouth) Therapeutics Sales by Type (2021-2032)
  4. 8.1.3 North America Xerostomia (Dry Mouth) Therapeutics Price by Type (2021-2032)
  5. 8.2 North America Xerostomia (Dry Mouth) Therapeutics Market Size by Application
  6. 8.2.1 North America Xerostomia (Dry Mouth) Therapeutics Revenue by Application (2021-2032)
  7. 8.2.2 North America Xerostomia (Dry Mouth) Therapeutics Sales by Application (2021-2032)
  8. 8.2.3 North America Xerostomia (Dry Mouth) Therapeutics Price by Application (2021-2032)
  9. 8.3 North America Xerostomia (Dry Mouth) Therapeutics Market Size by Country
  10. 8.3.1 North America Xerostomia (Dry Mouth) Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Xerostomia (Dry Mouth) Therapeutics Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Xerostomia (Dry Mouth) Therapeutics Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Xerostomia (Dry Mouth) Therapeutics Market Size by Type
  2. 9.1.1 Europe Xerostomia (Dry Mouth) Therapeutics Revenue by Type (2021-2032)
  3. 9.1.2 Europe Xerostomia (Dry Mouth) Therapeutics Sales by Type (2021-2032)
  4. 9.1.3 Europe Xerostomia (Dry Mouth) Therapeutics Price by Type (2021-2032)
  5. 9.2 Europe Xerostomia (Dry Mouth) Therapeutics Market Size by Application
  6. 9.2.1 Europe Xerostomia (Dry Mouth) Therapeutics Revenue by Application (2021-2032)
  7. 9.2.2 Europe Xerostomia (Dry Mouth) Therapeutics Sales by Application (2021-2032)
  8. 9.2.3 Europe Xerostomia (Dry Mouth) Therapeutics Price by Application (2021-2032)
  9. 9.3 Europe Xerostomia (Dry Mouth) Therapeutics Market Size by Country
  10. 9.3.1 Europe Xerostomia (Dry Mouth) Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Xerostomia (Dry Mouth) Therapeutics Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Xerostomia (Dry Mouth) Therapeutics Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Xerostomia (Dry Mouth) Therapeutics Market Size by Type
  2. 10.1.1 China Xerostomia (Dry Mouth) Therapeutics Revenue by Type (2021-2032)
  3. 10.1.2 China Xerostomia (Dry Mouth) Therapeutics Sales by Type (2021-2032)
  4. 10.1.3 China Xerostomia (Dry Mouth) Therapeutics Price by Type (2021-2032)
  5. 10.2 China Xerostomia (Dry Mouth) Therapeutics Market Size by Application
  6. 10.2.1 China Xerostomia (Dry Mouth) Therapeutics Revenue by Application (2021-2032)
  7. 10.2.2 China Xerostomia (Dry Mouth) Therapeutics Sales by Application (2021-2032)
  8. 10.2.3 China Xerostomia (Dry Mouth) Therapeutics Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Xerostomia (Dry Mouth) Therapeutics Market Size by Type
  2. 11.1.1 Asia Xerostomia (Dry Mouth) Therapeutics Revenue by Type (2021-2032)
  3. 11.1.2 Asia Xerostomia (Dry Mouth) Therapeutics Sales by Type (2021-2032)
  4. 11.1.3 Asia Xerostomia (Dry Mouth) Therapeutics Price by Type (2021-2032)
  5. 11.2 Asia Xerostomia (Dry Mouth) Therapeutics Market Size by Application
  6. 11.2.1 Asia Xerostomia (Dry Mouth) Therapeutics Revenue by Application (2021-2032)
  7. 11.2.2 Asia Xerostomia (Dry Mouth) Therapeutics Sales by Application (2021-2032)
  8. 11.2.3 Asia Xerostomia (Dry Mouth) Therapeutics Price by Application (2021-2032)
  9. 11.3 Asia Xerostomia (Dry Mouth) Therapeutics Market Size by Country
  10. 11.3.1 Asia Xerostomia (Dry Mouth) Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Xerostomia (Dry Mouth) Therapeutics Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Xerostomia (Dry Mouth) Therapeutics Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Xerostomia (Dry Mouth) Therapeutics Market Size by Type
  2. 12.1.1 SAMEA Xerostomia (Dry Mouth) Therapeutics Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Xerostomia (Dry Mouth) Therapeutics Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Xerostomia (Dry Mouth) Therapeutics Price by Type (2021-2032)
  5. 12.2 SAMEA Xerostomia (Dry Mouth) Therapeutics Market Size by Application
  6. 12.2.1 SAMEA Xerostomia (Dry Mouth) Therapeutics Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Xerostomia (Dry Mouth) Therapeutics Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Xerostomia (Dry Mouth) Therapeutics Price by Application (2021-2032)
  9. 12.3 SAMEA Xerostomia (Dry Mouth) Therapeutics Market Size by Country
  10. 12.3.1 SAMEA Xerostomia (Dry Mouth) Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Xerostomia (Dry Mouth) Therapeutics Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Xerostomia (Dry Mouth) Therapeutics Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Xerostomia (Dry Mouth) Therapeutics Value Chain Analysis
  2. 13.1.1 Xerostomia (Dry Mouth) Therapeutics Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Xerostomia (Dry Mouth) Therapeutics Production Mode & Process
  6. 13.2 Xerostomia (Dry Mouth) Therapeutics Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Xerostomia (Dry Mouth) Therapeutics Distributors
  9. 13.2.3 Xerostomia (Dry Mouth) Therapeutics Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst